Santos Joana A, Aróstegui Juan I, Brito Maria J, Neves Conceição, Conde Marta
Pediatric Department, Hospital Dona Estefânia, CHLC, EPE, Lisbon, Portugal.
Immunology Department, Hospital Clínic-IDIBAPS, Barcelona, Spain.
Gene. 2014 Jun 1;542(2):217-20. doi: 10.1016/j.gene.2014.03.031. Epub 2014 Mar 18.
Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS; MIM# 260920) is a rare recessively-inherited autoinflammatory condition caused by mutations in the MVK gene, which encodes for mevalonate kinase, an essential enzyme in the isoprenoid pathway. HIDS is clinically characterized by recurrent episodes of fever and inflammation. Here we report on the case of a 2 year-old Portuguese boy with recurrent episodes of fever, malaise, massive cervical lymphadenopathy and hepatosplenomegaly since the age of 12 months. Rash, arthralgia, abdominal pain and diarrhea were also seen occasionally. During attacks a vigorous acute-phase response was detected, including elevated erythrocyte sedimentation rate, C-reactive protein, serum amyloid A and leukocytosis. Clinical and laboratory improvement was seen between attacks. Despite normal serum IgD level, HIDS was clinically suspected. Mutational MVK analysis revealed the homozygous genotype with the novel p.Arg277Gly (p.R277G) mutation, while the healthy non-consanguineous parents were heterozygous. Short nonsteroidal anti-inflammatory drugs and corticosteroid courses were given during attacks with poor benefits, whereas anakinra showed positive responses only at high doses. The p.R277G mutation here described is a novel missense MVK mutation, and it has been detected in this case with a severe HIDS phenotype. Further studies are needed to evaluate a co-relation genotype, enzyme activity and phenotype, and to define the best therapeutic strategies.
高免疫球蛋白D血症和周期性发热综合征(HIDS;MIM# 260920)是一种罕见的隐性遗传自身炎症性疾病,由MVK基因突变引起,该基因编码甲羟戊酸激酶,这是类异戊二烯途径中的一种关键酶。HIDS的临床特征为发热和炎症反复发作。本文报道了一名2岁葡萄牙男孩的病例,自12个月大以来,他反复出现发热、不适、颈部淋巴结肿大和肝脾肿大。偶尔还可见皮疹、关节痛、腹痛和腹泻。发作期间检测到强烈的急性期反应,包括红细胞沉降率、C反应蛋白、血清淀粉样蛋白A升高和白细胞增多。发作间期临床和实验室指标有所改善。尽管血清IgD水平正常,但临床怀疑为HIDS。MVK基因突变分析显示为纯合基因型,带有新的p.Arg277Gly(p.R277G)突变,而健康的非近亲父母为杂合子。发作期间给予短效非甾体抗炎药和皮质类固醇疗程,效果不佳,而阿那白滞素仅在高剂量时显示出阳性反应。本文描述的p.R277G突变是一种新的甲羟戊酸激酶错义突变,在该病例中检测到的是严重的HIDS表型。需要进一步研究以评估基因型、酶活性和表型之间的相关性,并确定最佳治疗策略。